About Lunit
Lunit is a company based in Seoul (South Korea) founded in 2013. It operates as a AI-as-a-Service. Lunit has raised $133.16 million across 7 funding rounds from investors including Guardant Health, NH Investment & Securities and LG CNS. The company has 320 employees as of December 31, 2024. Lunit has completed 1 acquisition, including Volpara Health. Lunit offers products and services including Cancer Screening AI and Cancer Treatment AI. Lunit operates in a competitive market with competitors including Median, Oxipit, Dxcover, SimBioSys and Aidence, among others.
- Headquarter Seoul, South Korea
- Employees 320 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Lunit Inc.
-
Annual Revenue
$36.74 M (USD)116.03as on Dec 31, 2024
-
Net Profit
$-55.89 M (USD)-123.98as on Dec 31, 2024
-
EBITDA
$-40.66 M (USD)-53.5as on Dec 31, 2024
-
Total Equity Funding
$133.16 M (USD)
in 7 rounds
-
Latest Funding Round
$61 M (USD), Series C
Nov 25, 2021
-
Investors
Guardant Health
& 18 more
-
Employee Count
320
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Lunit
Lunit is a publicly listed company on the KRX with ticker symbol 328130 in South Korea, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Lunit
Lunit offers a comprehensive portfolio of products and services, including Cancer Screening AI and Cancer Treatment AI. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI is used for early-stage cancer detection.
AI predicts immunotherapy response for better efficacy.
Unlock access to complete
Unlock access to complete
Funding Insights of Lunit
Lunit has successfully raised a total of $133.16M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $61 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series C — $61.0M
-
First Round
First Round
(01 Jun 2014)
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2021 | Amount | Series C - Lunit | Valuation | Health Quest Capital , Casdin Capital |
|
| Jul, 2021 | Amount | Series C - Lunit | Valuation | Guardant Health | |
| Jan, 2020 | Amount | Series C - Lunit | Valuation | Shinhan Investment Corp |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Lunit
Lunit has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include Guardant Health, NH Investment & Securities and LG CNS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on tech and life sciences startups.
|
Founded Year | Domain | Location | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
BrightEdge is focused on impact investment in cancer care innovation.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Lunit
Lunit has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Volpara Health. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
AI-based clinical decision support and cancer diagnosis tool for providers
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Lunit
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Lunit Comparisons
Competitors of Lunit
Lunit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Median, Oxipit, Dxcover, SimBioSys and Aidence, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical imaging software and services are provided for clinical trials.
|
|
| domain | founded_year | HQ Location |
Artificial intelligence is used for analyzing medical images in healthcare.
|
|
| domain | founded_year | HQ Location |
AI-powered device developed for early brain tumor diagnosis.
|
|
| domain | founded_year | HQ Location |
AI-based cancer diagnosis tools are provided for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Medical images are analyzed using deep learning for radiologists.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Lunit
Frequently Asked Questions about Lunit
When was Lunit founded?
Lunit was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Lunit located?
Lunit is headquartered in Seoul, South Korea.
Is Lunit a funded company?
Lunit is a funded company, having raised a total of $133.16M across 7 funding rounds to date. The company's 1st funding round was a Series C of $26M, raised on Jun 01, 2014.
How many employees does Lunit have?
As of Dec 31, 2024, the latest employee count at Lunit is 320.
What is the annual revenue of Lunit?
Annual revenue of Lunit is $36.74M as on Dec 31, 2024.
What does Lunit do?
Lunit is engaged in creating AI-driven solutions for cancer screening and treatment. The company operates in the healthcare sector, specializing in medical technology. Its AI tools are designed for early detection of cancers to enable timely intervention and for predicting immunotherapy responses to enhance treatment efficacy. Lunit collaborates with global research and business partners across over 50 countries, supporting precision oncology and expanding access to AI in public healthcare systems.
What products or services does Lunit offer?
Lunit offers Cancer Screening AI and Cancer Treatment AI.
Is Lunit publicly traded?
Yes, Lunit is publicly traded on KRX under the ticker symbol 328130.
How many acquisitions has Lunit made?
Lunit has made 1 acquisition, including Volpara Health.
Who are Lunit's investors?
Lunit has 19 investors. Key investors include Guardant Health, NH Investment & Securities, LG CNS, Shinhan Financial Group, and Health Quest Capital.
What is Lunit's ticker symbol?
The ticker symbol of Lunit is 328130 on KRX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.